UNSPSC 85505110: Insertion of infusion device into left ulnar artery, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of infusion device into left ulnar artery, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03HA43Z

UNSPSC 85505110 Insertion of infusion device into left ulnar artery, percutaneous endoscopic approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific clinical procedure — percutaneous endoscopic insertion of an infusion device into the left ulnar artery — yet the recent opportunities tagged under it reflect a far broader scope: independent medical evaluation services, occupational health surveillance, specialty surgical networks, pharmacy benefit management, temporary health professional staffing, and youth detention healthcare services. These solicitations do not involve insertion of infusion devices into ulnar arteries and appear misclassified under this code.

State and local healthcare purchasing bodies including the City of Phoenix Retirement Office, Washington State Department of Transportation, City of Long Beach, Collier County, Harris County, and County of Santa Clara Health System have all used this code tag in recent months, but the actual work being solicited spans administrative medical services, occupational medicine compliance, surgical procedure management through centers of excellence, pharmacy administration, temporary clinical staffing, and detention facility medical care — none of which corresponds to the code's nominal commodity. The geographic spread includes Arizona, Washington, California, Texas, and Florida across the recent postings. Because the code's abstract name bears no meaningful relationship to what these jurisdictions are actually buying, treating it as a reliable signal for procurement opportunity under this specific clinical procedure would be misleading.